In conclusion, we provide an evidence for the presence of the VDR, CYB27B1, CYP24A1, RORα and RORγ in uveal cells, which changes in uveal melanomas and suggest that these proteins are involved in clinical presentation and represent targets for novel therapeutic approaches. This evidence concerns the gene CYP24A1 and uveal melanoma.